Form 4 for ICUI ICU MEDICAL INC/DE
Accepted 2026-03-16 00:00:00 ET · period of report 2026-03-15 · accession 0001727477-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-16 | 2026-03-15 | ICUI | Voigtlander Christian B. | COO | F - Tax | $125.85 | -8,096 | 44.9K | -15% | -$1.02M |
| DM | 2026-03-16 | 2026-03-15 | ICUI | Voigtlander Christian B. | COO | M - OptEx | $0.00 | +14.6K | 51.2K | +40% | $0 |
| DM | 2026-03-16 | 2026-03-15 | ICUI | Voigtlander Christian B. | COO | M - OptEx | $0.00 | -14.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-15 | F | D | 1,795 | $125.85 | 46,306 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-15 | F | D | 6,301 | $125.85 | 44,853 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-15 | M | A | 3,248 | $0.00 | 48,101 | D | — | — | (F3) These securities are Restricted Stock Units. |
| 4 | Common | Common Stock | 2026-03-15 | M | A | 11,400 | $0.00 | 51,154 | D | — | — | (F1) These Securities are Performance-based Restricted Stock Units (PRSU). (F2) Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein. |
| 5 | Derivative | Performance Shares | 2026-03-15 | M | D | 11,400 | $0.00 | 0 | D | $0.00 · 2026-03-15 to 2026-03-15 | 11,400 Common Stock | (F1) These Securities are Performance-based Restricted Stock Units (PRSU). (F2) Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein. (F5) There is neither a purchase price nor an exercise price for the PRSUs. |
| 6 | Derivative | Common Stock | 2026-03-15 | M | D | 3,248 | $0.00 | 0 | D | $0.00 · 2026-03-15 to 2026-03-15 | 3,248 Common Stock | (F3) These securities are Restricted Stock Units. (F4) There is neither a purchase price nor an exercise price for the Restricted Stock Units. |